Related Experiment Video
Updated: Nov 16, 2025

Validated LC-MS/MS Panel for Quantifying 11 Drug-Resistant TB Medications in Small Hair Samples
Published on: May 19, 2020
Pharmacy based surveillance for identifying missing tuberculosis cases: A mixed methods study from South India.
Asha Frederick1, Mrinalini Das2, Kedar Mehta3
1Thoracic Medicine, Revised National Tuberculosis Control Programme, Dharmapuri, Tamil Nadu, India.
Pharmacy-based surveillance identified a significant number of previously un-notified tuberculosis (TB) patients, contributing substantially to overall TB notification in India. Strengthening this system is crucial for improving TB case detection and control efforts nationwide.
Area of Science:
- Public Health
- Epidemiology
- Health Policy Implementation
Background:
- Limited Indian research exists on pharmacy-based surveillance for tuberculosis (TB) notification.
- Recent policies aim to leverage pharmacies for TB surveillance, but their impact is unassessed.
Purpose of the Study:
- To evaluate pharmacy-based TB surveillance and notification in India.
- To understand program managers' and pharmacists' experiences with implementation.
Main Methods:
- A mixed-methods approach combining quantitative (cross-sectional) and qualitative (in-depth interviews) data.
- Study conducted in Dharmapuri and Salem districts, Tamil Nadu, India.
Main Results:
- Pharmacies reported anti-TB drug sales, identifying 20-29% of total notified TB patients as previously un-notified.
- Key enablers included understanding notification importance, resources, training, and partnerships.
- Barriers involved patient confidentiality concerns, complex reporting, and high workload.
Conclusions:
- Pharmacy-based surveillance significantly contributes to TB notification, identifying approximately one-fourth of cases in the studied districts.
- Implementation requires strengthening and scaling up across India to enhance TB control.
More Related Videos
09:57System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
Published on: April 5, 2017
09:54Synthesis, Characterization, and Application of Superparamagnetic Iron Oxide Nanoprobes for Extrapulmonary Tuberculosis Detection
Published on: February 16, 2020
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories: